US Revenue Cycle Management Market Size To Cross USD 312 Bn By 2030

The US revenue cycle management market size accounted for US$ 142.99  Bn in 2022 and is projected to reach around USD 142.99  Bn by 2030, growing at a CAGR of 10.24% from 2022 to 2030.

Report Summary

The global US revenue cycle management market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the US revenue cycle management market across the globe.

A comprehensive estimate on the US revenue cycle management market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of US revenue cycle management during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2431

US Revenue Cycle Management Market Report Scope 

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized US revenue cycle management market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Ammonia Market Size To Cross USD 129.63 Bn By 2030

US Revenue Cycle Management Market Players

The report includes the profiles of key US revenue cycle management market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

• Allscripts Healthcare Solutions
• Change Healthcare Inc.
• Cognizant Technology Solutions Corp.
• Computer Programs and Systems Inc.
• Experian Plc
• Medical Information Technology Inc.
• MEDIREVV
• OSP Labs
• Quest Diagnostics Inc.
• R1 RCM Inc.

Market Segmentation

By Product

• Software
• Services

By Type

• Integrated
• Standalone

By Function

• Product Development
• Member Engagement
• Network Management
• Care Management
• Claims Management
• Risk and Compliances

By Delivery Mode

• Web based
• Cloud based

By Physician Specialty

• Oncology
• Cardiology
• Anesthesia
• Radiology
• Pathology
• Pain Management
• Emergency Service
• Others

By Sourcing

• In-house
• External RCM Apps/ Software
• Outsourced RCM Services

By End User

• Physician Back office,
• Hospitals
• Diagnostic Laboratories
• Other

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Revenue Cycle Management Market 

5.1. COVID-19 Landscape: US Revenue Cycle Management Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global US Revenue Cycle Management Market, By Function

8.1. US Revenue Cycle Management Market, by Function, 2022-2030

8.1.1. Product Development

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Member Engagement

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Network Management

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Care Management

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Claims Management

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Risk and Compliances

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global US Revenue Cycle Management Market, By Product

9.1. US Revenue Cycle Management Market, by Product, 2022-2030

9.1.1. Software

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Services

Chapter 10. Global US Revenue Cycle Management Market, By Type 

10.1. US Revenue Cycle Management Market, by Type, 2022-2030

10.1.1. Integrated

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Standalone

Chapter 11. Global US Revenue Cycle Management Market, By Delivery Mode

11.1. US Revenue Cycle Management Market, by Delivery Mode, 2022-2030

11.1.1. Web based

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cloud based

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global US Revenue Cycle Management Market, By End User

12.1. US Revenue Cycle Management Market, by End User, 2022-2030

12.1.1. Physician Back office

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Diagnostic Laboratories

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Other

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global US Revenue Cycle Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.5. Market Revenue and Forecast, by End User (2017-2030)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.7. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.8. Market Revenue and Forecast, by End User (2017-2030)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.10. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Allscripts Healthcare Solutions

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Change Healthcare Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cognizant Technology Solutions Corp.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Computer Programs and Systems Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Experian Plc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Medical Information Technology Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. MEDIREVV

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. OSP Labs

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quest Diagnostics Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. R1 RCM Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com